DiaSorin (DSRLF)
(Delayed Data from OTC)
$107.88 USD
0.00 (0.00%)
Updated Nov 1, 2024 03:35 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DSRLF 107.88 0.00(0.00%)
Will DSRLF be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for DSRLF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DSRLF
New Strong Sell Stocks for January 29th
DSRLF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for DSRLF
HSBC gets more bearish on DiaSorin, downgrades shares
DiaSorin price target raised by EUR 7 at Berenberg
Invesco International Small-Mid Company Fund Q2 2024 Review